The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production

T. Ishikawa, K. Nakayama, J. Mikami, S. Ito, N. Takasaka, Y. Yumino, S. Fujii, C. Tsurushige, J. Kojima, T. Numata, H. Hara, M. Kawaishi, J. Araya, K. Kuwano (Tokyo, Japan)

Source: Annual Congress 2013 –COPD: experimental biology
Session: COPD: experimental biology
Session type: Thematic Poster Session
Number: 620
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Ishikawa, K. Nakayama, J. Mikami, S. Ito, N. Takasaka, Y. Yumino, S. Fujii, C. Tsurushige, J. Kojima, T. Numata, H. Hara, M. Kawaishi, J. Araya, K. Kuwano (Tokyo, Japan). The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production. Eur Respir J 2013; 42: Suppl. 57, 620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014

Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Source: Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018
Year: 2019



COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013


Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

GM-CSF is a key pathogenic mediator in experimental COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005

Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD
Source: Eur Respir J, 55 (2) 1900563; 10.1183/13993003.00563-2019
Year: 2020



The investigation of the role of interleukin (IL)-17 in COPD and asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005

IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013

The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Increased circulating endothelial microparticles in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006

The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016